Gt. Ramesh et al., Lead exposure activates nuclear factor kappa B, activator protein-1, c-JunN-terminal kinase and caspases in the rat brain, TOX LETT, 123(2-3), 2001, pp. 195-207
How lead manifests its neurotoxicity is not well understood. The hypothesis
that lead may activate nuclear transcription factors NF-kappaB, activator
protein-1 (AP-1), c-Jun N-terminal kinase (JNK), mitogen-activated protein
kinase kinase (MAPKK) and caspases in the rat brain leading to the manifest
ation of its neurotoxic effects, was tested in 21-day-old male Long-Evans r
ats exposed to 50 ppm Pb in drinking water for 90 days. After the 90-day ex
posure, blood lead levels of the rats in control group were 4 +/- 0.2 mug/d
l, while those of the Pb-exposed group were 18 +/- 0.3 mug/dl (n = 50). Sim
ilarly, at the end of the exposure period, the Pb-exposed group showed sign
ificantly higher accumulation of Pb in brain regions such as, frontal corte
x (FC), brain stem (BS), striatum (ST), and hippocampus (HIP) (338.6 +/- 7.
7, 391.6 +/- 3.8, 288.3 +/- 6.7, and 382.3 +/- 3.3 ng/g wet tissue, respect
ively, in FC, BS, ST, and HIP) than the control group (126.6 +/- 2.7, 127.6
+/- 1.8, 201.3 +/- 9.4, and 180.3 +/- 4.4 ng/g wet tissue, respectively, i
n FC, BS, ST, and HIP). There was a 3-4-fold increase in NF-kappaB and AP-1
level in all the four regions of the brain of lead-treated animals. All fo
ur regions showed 4-10-fold activation of JNK and a 5-6-fold activation of
MAPKK. As indicated by poly(ADP ribose) polymerase cleavage, lead exposure
induced the activation of caspases in all four regions. Overall our results
indicate that lead exposure induces the activation of NF-kappaB, AP-1, JNK
, MAPKK, and caspases in the brain, which may contribute to its neurotoxic
effects. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.